BUZZ- Cardiome Pharma Corp: Revenue jumps

Mon Aug 11, 2014 12:27pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Specialty pharmaceutical company's shares up 6.8 pct at $7.64

** The Canadian company's revenue in the latest quarter jumps to $7.7 million from $107,000 as sales of its new heart drug, Brinavess, continued to rise

** Brinavess, which has won marketing approval in the European Union, Iceland and Norway, is on clinical hold in the United States

** Sales of the company's blood thinner, Aggrastat, is falling due to generic competition

** In the 12 months to Friday's close, the company's stock had more than tripled